FARRELL MICHAEL J. (Chief Executive Officer) received a stock award from RESMED INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/1/2026ACC: 0000943819-26-000075
Officer· Chief Executive Officer
Since Aug 2018
+13.55K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
13.55K acquired
Non-Derivative Transactions1
ResMed Common Stock
Direct
Shares
+13.55K
Price / share
—
Trade value
—
% of position
2.9%
8/14/2026
466.26K→479.80K
Total
Net shares
+13.55K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 8/14/2026 | A · Award | +13.55K | — | — | 2.9% | 466.26K | 479.80K |
| Total | +13.55K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
ResMed Common Stock
IndirectShares owned2.09K
Total
2.09K indirect2.09K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| ResMed Common Stock | 2.09K | Indirect |
| Total | 2.09K | 2.09K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported